SAN DIEGO--(BUSINESS WIRE)--Orexigen™ Therapeutics (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders including obesity, will be hosting a reception for analysts and investors on Wednesday, December 5, 2007 from 11:30 a.m. to 2:30 p.m. Eastern Time at the 21 Club on 21 West 52nd Street in New York City. In addition to presentations from the Orexigen management team, the program will feature guest speakers including Louis Aronne, M.D., FACP, a leading authority in the treatment of obesity from Weill Medical College of Cornell University, and Gene-Jack Wang, M.D., a food addiction and brain imaging expert from the Brookhaven National Laboratory.
